Skip to content Skip to navigation

Shift Happens: The New Wave in Addictions M&A and What It May Mean to You

Wednesday May 18, 2016 | 2:00 p.m. ET, 1:00 p.m. CT

The mergers and acquisitions market in addictions and substance abuse is at an inflection point. Demand is beginning to shift from a largely high-end, out-of-network residential focus, to value-oriented, in-network and community-based programs that may be short on sex appeal, but long on cost, growth, and stability appeal. 

We are already seeing this subtle shift in the recent swell of transaction activity involving medication-assisted treatment providers. In this session, Dexter Braff will discuss why the substance abuse deal climate is in transition and how this may reshape investment strategies, demand, and valuation in addictions M&A over the next 12 to 36 months.  

Learning Objectives:

  • Discuss how the trajectory in addictions and substance abuse M&A has recently played out
  • Describe the factors that are reshaping the acquisitions market
  • Relate how changes will impact acquisition candidate supply and demand, deal flow and valuations over the next 12 to 26 months

Dexter Braff, MBA, BS, MA
The Braff Group

With nearly 30 years of experience representing healthcare service companies, Dexter is recognized as the industry expert in healthcare mergers and acquisitions. He has written and contributed to feature articles that have appeared in numerous healthcare industry publications and has written a chapter in the Handbook of Business Valuation published by John Wiley & Sons. He is frequently interviewed on various topics regarding healthcare M&A by news outlets including Bloomberg News, CNBC, USA Today, The Huffington Post, The Palm Beach Times, and numerous healthcare sector journals.

Additionally, the firm is the publisher of marketWATCH, a quarterly review of mergers and acquisitions activity in five industry segments: Behavioral Health Care, Home Health and Hospice, Pharmacy Services, Urgent Care, and Home Medical Equipment.